The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens.
Eli Lilly to Buy 3 Vaccine Developers
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Leave a Reply